We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Northw.Bio Di | LSE:NWBT | London | Ordinary Share | COM SHS USD0.001 (DI) |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 15.00 | 0.00 | 01:00:00 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | O | 0 | 15.00 | GBX |
Northw.Bio Di (NWBT) Share Charts1 Year Northw.Bio Di Chart |
|
1 Month Northw.Bio Di Chart |
Intraday Northw.Bio Di Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 02/9/2020 | 22:01 | Northwest Biotherapeutics | 2 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 10/10/2007 14:02 by kozel NWBT have developed the world's first therapeutic vaccine for Brain Cancer, DCVax(R)-Brain, which is commercially available to patients in Switzerland. Clinical trial data has shown that the vaccine delays disease recurrence by nearly 3-fold, from 6.9 months to 18.1 months for newly diagnosed patients, and also extends these patients' survival from 14.6 months to more than 33 months. |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
